Incidence of stroke in patients with HIV infection: A population-based study in Taiwan.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 28 10 2018
accepted: 06 05 2019
entrez: 23 5 2019
pubmed: 23 5 2019
medline: 30 1 2020
Statut: epublish

Résumé

Few studies have evaluated whether people infected with human immunodeficiency virus (HIV) are at an increased risk of stroke in an Asian population. We investigated the association between HIV infection and the risk of developing stroke by age, calendar year of HIV diagnosis, and follow-up duration in Taiwan. Using the claims data of a universal health insurance program, we identified 5,961 patients with HIV and 23,844 matched non-HIV subjects without previous stroke from 1998 to 2005 and followed them up until the end of 2011 to measure the incidence of stroke. Cox proportional hazards models adjusted for potential confounders were used to estimate hazard ratios (HR) and 95% confidence intervals (CI), with the non-HIV group as reference. During a median follow-up of 8 years, the incidence rates for total, ischemic, and hemorrhagic stroke per 1000 person-years were 2.12, 1.22, and 0.60, respectively, in patients with HIV infection, and 1.98, 1.14, and 0.54, respectively, in the comparison group. HIV infection was associated with an elevated risk of developing total stroke (adjusted HR [95% CI], 1.57 [1.15-2.14]) and ischemic stroke (1.91 [1.25-2.91]) in patients aged less than 45 years, but no association was observed in other age groups (P for interaction with age, p = 0.048 and 0.024, respectively). Patients diagnosed with HIV infection in 1998-1999 had a greater HR for total stroke and ischemic stroke than those diagnosed in 2000-2002 and 2003-2005 (P for interaction, for total stroke p = 0.034, for ischemic stroke p = 0.056). The HRs did not differ by follow-up duration. HIV infection among a young age group is associated with increased risk of developing overall and ischemic stroke. The findings highlight the importance of screening and correcting risk factors for young stroke prevention immediately and aggressively.

Sections du résumé

BACKGROUND
Few studies have evaluated whether people infected with human immunodeficiency virus (HIV) are at an increased risk of stroke in an Asian population. We investigated the association between HIV infection and the risk of developing stroke by age, calendar year of HIV diagnosis, and follow-up duration in Taiwan.
METHODS
Using the claims data of a universal health insurance program, we identified 5,961 patients with HIV and 23,844 matched non-HIV subjects without previous stroke from 1998 to 2005 and followed them up until the end of 2011 to measure the incidence of stroke. Cox proportional hazards models adjusted for potential confounders were used to estimate hazard ratios (HR) and 95% confidence intervals (CI), with the non-HIV group as reference.
RESULTS
During a median follow-up of 8 years, the incidence rates for total, ischemic, and hemorrhagic stroke per 1000 person-years were 2.12, 1.22, and 0.60, respectively, in patients with HIV infection, and 1.98, 1.14, and 0.54, respectively, in the comparison group. HIV infection was associated with an elevated risk of developing total stroke (adjusted HR [95% CI], 1.57 [1.15-2.14]) and ischemic stroke (1.91 [1.25-2.91]) in patients aged less than 45 years, but no association was observed in other age groups (P for interaction with age, p = 0.048 and 0.024, respectively). Patients diagnosed with HIV infection in 1998-1999 had a greater HR for total stroke and ischemic stroke than those diagnosed in 2000-2002 and 2003-2005 (P for interaction, for total stroke p = 0.034, for ischemic stroke p = 0.056). The HRs did not differ by follow-up duration.
CONCLUSIONS
HIV infection among a young age group is associated with increased risk of developing overall and ischemic stroke. The findings highlight the importance of screening and correcting risk factors for young stroke prevention immediately and aggressively.

Identifiants

pubmed: 31116762
doi: 10.1371/journal.pone.0217147
pii: PONE-D-18-31077
pmc: PMC6530842
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0217147

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

AIDS. 2016 Jan 2;30(1):45-55
pubmed: 26372478
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5199-204
pubmed: 11320252
HIV Med. 2019 Mar;20(3):183-191
pubmed: 30620108
J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):351-8
pubmed: 22580566
AIDS. 2011 Aug 24;25(13):1637-46
pubmed: 21646903
Open AIDS J. 2017 Aug 21;11:52-66
pubmed: 29302277
Health Aff (Millwood). 2003 May-Jun;22(3):61-76
pubmed: 12757273
J Neurol. 2012 Jul;259(7):1347-53
pubmed: 22231865
Lancet Neurol. 2012 Oct;11(10):878-90
pubmed: 22995692
JAMA Intern Med. 2013 Apr 22;173(8):614-22
pubmed: 23459863
Neurology. 2011 Feb 1;76(5):444-50
pubmed: 21248273
PLoS One. 2016 Mar 17;11(3):e0151684
pubmed: 26986005
Lancet Neurol. 2008 Apr;7(4):341-53
pubmed: 18339349
Arch Neurol. 1995 Nov;52(11):1119-22
pubmed: 7487564
Cerebrovasc Dis Extra. 2015 Mar 20;5(1):28-30
pubmed: 25960735
Curr Opin Infect Dis. 2006 Feb;19(1):1-7
pubmed: 16374210
J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e34-41
pubmed: 22554568
Clin Infect Dis. 2006 Sep 1;43(5):e46-50
pubmed: 16886142
Cerebrovasc Dis. 1998 Jul-Aug;8(4):222-7
pubmed: 9684062
PLoS One. 2012;7(3):e33765
pubmed: 22479439
J Clin Pathol. 2001 Apr;54(4):275-8
pubmed: 11304843
Ann Neurol. 1990 Sep;28(3):303-11
pubmed: 2241113
Neurology. 2015 May 12;84(19):1933-40
pubmed: 25862803
Hippokratia. 2008 Apr;12(2):98-102
pubmed: 18923652
Stroke. 2009 Apr;40(4):1195-203
pubmed: 19246709
Lancet. 2012 Dec 15;380(9859):2197-223
pubmed: 23245608
J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1320-4
pubmed: 17470469
Neurology. 2014 Nov 4;83(19):1705-11
pubmed: 25280902
Ther Adv Chronic Dis. 2013 Mar;4(2):61-70
pubmed: 23556125
Cerebrovasc Dis Extra. 2013 Oct 18;3(1):137-49
pubmed: 24348498
AIDS. 2014 Aug 24;28(13):1911-9
pubmed: 24937309
AIDS. 2018 Jan 2;32(1):59-67
pubmed: 28926405
Int J Neurosci. 2015;125(8):601-11
pubmed: 25158008
J Neurol Sci. 1996 Nov;143(1-2):187-9
pubmed: 8981323
J Neurovirol. 2016 Oct;22(5):634-640
pubmed: 27044037
J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):117-125
pubmed: 27787346
PLoS One. 2017 Jun 15;12(6):e0179493
pubmed: 28617855
AIDS. 2018 Jun 1;32(9):1125-1135
pubmed: 29746317
AIDS Res Hum Retroviruses. 2013 Jul;29(7):1068-74
pubmed: 23565888

Auteurs

Hui-Lin Lin (HL)

PHD Program for Aging, China Medical University, Taichung, Taiwan.
Department of Physical Medicine and Rehabilitation, Lin Shin Hospital, Taichung, Taiwan.

Chih-Hsin Muo (CH)

Department of Public Health, China Medical University, Taichung, Taiwan.

Cheng-Yu Lin (CY)

Department of Public Health, China Medical University, Taichung, Taiwan.

Hsuan-Ju Chen (HJ)

Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan.

Pei-Chun Chen (PC)

Department of Public Health, China Medical University, Taichung, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH